51 results
Page 3 of 3
424B5
ti5xm04l
26 Aug 20
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
4ko2djx1xai8xbmcw
25 Aug 20
Other Events
7:00am
8-K
EX-99.2
ig3gwlw3dkl
25 Aug 20
Other Events
7:00am
8-K
EX-99.1
znj8wd2q5cz
10 Aug 20
Ovid Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
8:06am
8-K
EX-99.1
l0i8yyg
19 Jun 20
Ovid Therapeutics Receives FDA Rare Pediatric Disease Designation for OV101 for the Treatment of Angelman Syndrome
8:06am
8-K
EX-99.1
viiq8a8e5rr 1xyvx0
17 Jun 20
Regulation FD Disclosure
1:11pm
8-K
EX-99.2
4acvmxt
7 May 20
Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
8:10am
8-K
EX-99.1
mwburwgmcy1tse
7 May 20
Ovid Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
8:10am
8-K
EX-99.1
y9s4msyg16
30 Mar 20
Ovid Therapeutics Announces Initial Data with Soticlestat in CDKL5 Deficiency Disorder and Dup15q Syndrome
8:05am